Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
JCO Oncology Practice|November 9, 2023
Impact of Medication Reconciliation in Oncology Early Phase Studies: A Drug-Drug Interaction Retrospective StudyLaura Malifarge, Marine Deppenweiler, Antoine Italiano, et al.
Bulletin Du Cancer|March 2, 2015
[Is Herceptin(®) (trastuzumab) by subcutaneous a mini revolution? Pharmaco-economic study]Vincent Lieutenant, Émilie Toulza, Martine Pommier, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 22, 2018
Subcutaneous auto-administration of trastuzumab following therapeutic education: A case reportMarine Deppenweiler, Marc Debled, Jean-Luc Robquin, et al.
Cancer Chemotherapy and Pharmacology|February 26, 2010
"Metronomic" chemotherapy in advanced soft tissue sarcomasAntoine Italiano, Maud Toulmonde, Barbara Lortal, et al.
The Journal of Biological Chemistry|December 7, 2007
MAP1A light chain-2 interacts with GTP-RhoB to control epidermal growth factor (EGF)-dependent EGF receptor signalingIsabelle Lajoie-Mazenc, Daniel Tovar, Marie Penary, et al.
BMC Cancer|February 19, 2018
Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancerMarina Pulido, Guilhem Roubaud, Anne-Laure Cazeau, et al.
Breast Cancer (Tokyo, Japan)|April 18, 2024
French national survey on breast cancer care: caregiver and patient viewsChristine Rousset-Jablonski, Barbara Lortal, Sophie Lantheaume, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 16, 2023
CAR T-Cells for the Treatment of Refractory or Relapsed Large B-Cell Lymphoma: A Single-Center Retrospective Canadian StudyAurélie Benoit, Marie-Hélène B Boies, Nicole Déry, et al.
Pharmacological Research|February 15, 2018
Detection of drug safety signals from clinical trials data: Role of SUSARsChristelle Perez, Pascale Olivier, Barbara Lortal, et al.
Pageof 2